Coco,

Welcome to the board.

I believe word of mouth as you have demonstrated will spread like wild fire once Afrezza is approved. There will always be those fossils in the medical community which tie Afrezza to the failure we all know as Exubera. Other than the pathway into the body there are very few similarities between the 2 drugs.

Serial entrepreneurs like Alfred Mann spend their entire lifetime working on developing a better mouse trap. Afrezza is a home run IMO. All we need is for the fickle FDA to approve the drug. Patience will be rewarded.

Swing